“The rating continues to reflect our opinion of UHS’ growing business position as the area’s only academic medical center and leading trauma provider in a competitive market, fairly stable balance sheet during the past two fiscal years and relatively young average age of plant,” said S&P analyst Brian Williamson.
S&P also affirmed the “BBB+” rating on UHS’ series 2007 revenue bonds.
The outlook is stable, reflecting S&P’s view of UHS’ solid business position, fair debt service coverage and satisfactory liquidity.
More articles on healthcare finance:
GOP calls for halt to bundled payments, ACOs and other reforms
CRM is the new RCM: How strategic customer relationship management helps hospitals increase revenue and grow market share
For-profit hospital stock report: Week of Sept. 26-30
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
